MBMA data curation: How AI and expert meta-analysts get it right, fast
In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…
Matt Zierhut, PhD MBA2026年8月14日
Managing drug-drug interaction (DDI) risk for patients in clinical trials
Discover how DIDB® helps clinical teams assess drug-drug interaction risk, develop prohibited medication lists, &…
Katie Owens, PhD2026年8月12日
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis
Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…
Certara2026年7月16日
Enhancing clinical trials with real-world evidence in pregnancy research
Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…
Alekhya Lavu, PhD, PharmD2026年6月26日
Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices
Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…
Certara2026年6月22日
QSP modeling for Parkinson’s disease: Solving the synthetic control challenge in clinical trials
QSP modeling for Parkinson’s disease tackles optimized standard-of-care, placebo response, and missing biomarkers. See how…
Certara2026年6月11日
Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib
This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…
Dorottya Gui-Bodnar2026年5月28日
